Non-hodgkin lymphoma : prognostic factors and targets / / Peter J. Quesenberry, Jorge J. Castillo, editors

• Pubblicazione: New York, NY, : Humana Press, c2013
• Edizione: 1st ed. 2013.
• Descrizione fisica: 1 online resource (299 p.)
• Disciplina: 616.994460724
• Soggetto topico: Lymphomas - Risk factors; Lymphomas
• Altri autori: CastilloJorge J QuesenberryPeter J
• Note generali: Description based upon print version of record.
• Nota di bibliografia: Includes bibliographical references and index.
• Nota di contenuto: Cancer Stem Cells: A Matter of Perspective -- B and T-cell development -- HIV lymphomagenesis -- Epstein-Barr Virus Lymphomagenesis and Therapeutic Targets -- Antigen driven lymphomagenesis -- Pre-clinical lymphoma models -- Prognostic factors in B-cell lymphoma -- Prognostic factors in T-cell lymphoma -- Prognostic factors in HIV-associated lymphoma -- Future directions on the treatment of aggressive non-Hodgkin lymphoma -- New monoclonal antibodies for indolent non-Hodgkin lymphomas -- Current therapies for T-cell lymphoma -- Stem Cell Transplantation for lymphoma -- Autologous stem cell transplantation in non-Hodgkin lymphoma -- The role of Stem Cell Transplantation for HIV-associated lymphoma -- Stem Cell Transplantation for T-cell lymphoma -- Index.
• Sommario/riassunto: Recent developments in the therapy of non-Hodgkin lymphoma have improved response and survival rates in patients with these conditions. This book is focused on the biology, prognostic factors and novel targets of non-Hodgkin lymphoma. We believe that understanding the pathophysiology of non-Hodgkin lymphoma provides a mean to improve its risk-stratification and treatment. This book is intended for medical and healthcare professionals involved in the research and clinical care of patients with non-Hodgkin lymphoma.
• Titolo autorizzato: Non-hodgkin lymphoma
• ISBN: 1-299-33548-9; 1-4614-5851-X
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Lingua di pubblicazione: Inglese
• Record Nr.: 9910438027003321
• Lo trovi qui: Univ. Federico II
• Serie: Cancer Drug Discovery and Development, . 2196-9906